Mohamed J Saadh, Armaghan Lohrasbi, Elaheh Ghasemian, Marzieh Hashemian, Anahita Etemad, Zahra Dargahi, Vahab Hassan Kaviar
Background : Antibiotic resistance in cystic fibrosis (CF) is a well-known phenomenon. However, the comprehensive epidemiological impact of antibiotic resistance in CF is not clearly documented. So, this meta-analysis evaluated the proportion rates of carbapenem resistance (imipenem, meropenem, and doripenem) in CF based on publication date (1979-2000, 2001-2010, and 2011-2021), continents, pathogens, and antimicrobial susceptibility testing (AST). Methods : We searched studies in PubMed, Scopus, and Web of Science (until April 2021)...
December 2022: Yale Journal of Biology and Medicine